Showing 1 - 20 results of 8,591 for search '(((( has _ decrease ) OR ( _ ((stem decrease) OR (nn decrease)) ))) OR ( a large decrease ))', query time: 0.67s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

    <b>Supporting data for manuscript</b> "<b>Voluntary locomotion induces an early and remote hemodynamic decrease in the large cerebral veins</b>" by Kira Shaw (18796168)

    Published 2025
    “…<p dir="ltr">The CSV file 'Eyreetal_DrainingVein_SourceData' contains the averaged time series traces and extracted metrics from individual experiments used across Figures 1-5 in the manuscript "Voluntary locomotion induces an early and remote hemodynamic decrease in the large cerebral veins". The following acronyms included in the CSV file are defined as follows: Hbt is total hemoglobin, Art is artery region, DV is draining vein region, WV is whisker vein region, SEM is standard error mean, TS is time series, max peak is maximum peak, min peak is minima, AUC is area under the curve, WT is wild-type, AD is Alzheimer's disease, ATH is atherosclerosis and MIX is mixed AD/atherosclerosis. …”
  8. 8
  9. 9
  10. 10

    Data Sheet 1_Persistent lymphopenia after kidney transplantation: increased mortality and decreased homeostatic mechanisms.docx by Yun Liang (383275)

    Published 2025
    “…Mass cytometry immunophenotyping at 3 years showed that B cells, NK cells and all T cell subsets (CD4, CD8, naïve, memory, etc.) decreased with decreasing lymphocyte counts. This included fewer recent thymic emigrants, naïve T cells, and stem-cell like memory T cells (T<sub>SCM</sub>), suggesting an impaired homeostasis of peripheral T cells. …”
  11. 11

    Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

    Published 2025
    “…Ruxolitinib, a JAK/STAT inhibitor, has been shown to improve cutaneous manifestations of SLE. …”
  12. 12

    Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

    Published 2025
    “…Ruxolitinib, a JAK/STAT inhibitor, has been shown to improve cutaneous manifestations of SLE. …”
  13. 13

    Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

    Published 2025
    “…Ruxolitinib, a JAK/STAT inhibitor, has been shown to improve cutaneous manifestations of SLE. …”
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18

    Why Only the 2,6-Bis(o-Carborano)Pyridine-Stabilized Phosphenium Cation Has Succeeded in Splitting H<sub>2</sub>?: Key Design Insights for Next-Gen Phosphenium Pincer Catalysts by Mohmmad Faizan (14122382)

    Published 2025
    “…Among them, only the 2,6-bis(o-carborano)pyridine-stabilized phosphenium cation (<b>1</b><sup><b>+</b></sup>) has been shown to activate molecular hydrogen (H<sub>2</sub>). …”
  19. 19

    Why Only the 2,6-Bis(o-Carborano)Pyridine-Stabilized Phosphenium Cation Has Succeeded in Splitting H<sub>2</sub>?: Key Design Insights for Next-Gen Phosphenium Pincer Catalysts by Mohmmad Faizan (14122382)

    Published 2025
    “…Among them, only the 2,6-bis(o-carborano)pyridine-stabilized phosphenium cation (<b>1</b><sup><b>+</b></sup>) has been shown to activate molecular hydrogen (H<sub>2</sub>). …”
  20. 20

    Why Only the 2,6-Bis(o-Carborano)Pyridine-Stabilized Phosphenium Cation Has Succeeded in Splitting H<sub>2</sub>?: Key Design Insights for Next-Gen Phosphenium Pincer Catalysts by Mohmmad Faizan (14122382)

    Published 2025
    “…Among them, only the 2,6-bis(o-carborano)pyridine-stabilized phosphenium cation (<b>1</b><sup><b>+</b></sup>) has been shown to activate molecular hydrogen (H<sub>2</sub>). …”